Foghorn Therapeutics Inc. (FHTX) Current Ratio
- Current ratio · latest quarter: Value 3.36×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.36× | Current assets / current liabilities. $170.05M ÷ $50.58M ≈ 3.36× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 170.05M USD | Assets, Current |
| Current obligations | 50.58M USD | Liabilities, Current |
| Cash and equivalents | 68.08M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 3.21M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $170.05M | $50.58M | $68.08M | (m) | (m) | (m) | $3.21M | (m) | 3.36× |
| 2026-03-31 | $188.06M | $64.40M | $87.66M | (m) | (m) | (m) | $3.32M | (m) | 2.92× |
| 2025-12-31 | $163.24M | $59.74M | $80.88M | (m) | (m) | (m) | $4.27M | (m) | 2.73× |
| 2025-09-30 | $184.12M | $85.09M | $89.33M | (m) | (m) | (m) | $3.21M | (m) | 2.16× |
| 2025-06-30 | $203.84M | $77.79M | $72.57M | (m) | (m) | (m) | $3.32M | (m) | 2.62× |
| 2025-03-31 | $225.42M | $71.31M | $61.03M | (m) | (m) | (m) | $4.07M | (m) | 3.16× |
| 2024-12-31 | $249.60M | $66.99M | $55.45M | (m) | (m) | (m) | $3.79M | (m) | 3.73× |
| 2024-09-30 | $271.23M | $56.82M | $57.68M | (m) | (m) | (m) | $3.45M | (m) | 4.77× |
| 2024-06-30 | $289.62M | $50.87M | $138.95M | (m) | (m) | (m) | $4.81M | (m) | 5.69× |
| 2024-03-31 | $211.52M | $52.06M | $79.25M | (m) | (m) | (m) | $5.63M | (m) | 4.06× |
| 2023-12-31 | $240.18M | $58.44M | $80.34M | (m) | (m) | (m) | $6.26M | (m) | 4.11× |
| 2023-09-30 | $265.44M | $52.01M | $70.31M | (m) | (m) | (m) | $6.50M | (m) | 5.10× |
| 2023-06-30 | $290.49M | $56.64M | $57.70M | (m) | (m) | (m) | $6.93M | (m) | 5.13× |
| 2023-03-31 | $320.70M | $55.80M | $50.64M | (m) | (m) | (m) | $7.29M | (m) | 5.75× |
| 2022-12-31 | $351.40M | $55.20M | $52.21M | (m) | (m) | (m) | $5.41M | (m) | 6.37× |
| 2022-09-30 | $377.76M | $55.21M | $87.60M | (m) | (m) | (m) | $5.26M | (m) | 6.84× |
| 2022-06-30 | $400.07M | $47.97M | $61.21M | (m) | (m) | (m) | $3.63M | (m) | 8.34× |
| 2022-03-31 | $429.82M | $48.24M | $213.65M | (m) | (m) | (m) | $5.07M | (m) | 8.91× |
| 2021-12-31 | $459.56M | $48.69M | $101.14M | (m) | (m) | (m) | $3.82M | (m) | 9.44× |
| 2021-09-30 | $123.95M | $19.30M | $57.84M | (m) | (m) | (m) | $3.82M | (m) | 6.42× |
| 2021-06-30 | $144.67M | $16.41M | $125.17M | (m) | (m) | (m) | $3.41M | (m) | 8.81× |
| 2021-03-31 | $165.31M | $16.33M | $66.45M | (m) | (m) | (m) | $2.91M | $0.00 | 10.12× |
| 2020-12-31 | $190.69M | $18.85M | $92.80M | (m) | (m) | (m) | $3.68M | (m) | 10.12× |
| 2020-09-30 | $77.76M | $21.30M | $74.62M | (m) | (m) | (m) | $3.55M | $5.99M | 3.65× |
| 2019-12-31 | $16.89M | $12.65M | $14.98M | (m) | (m) | (m) | $3.44M | $4.15M | 1.33× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |